Definition and risk factors of early recurrence based on affecting prognosis of esophageal squamous cell carcinoma patients after radical resection

被引:9
作者
Zhang, Yaowen [1 ]
Gao, Junhui [2 ]
Zheng, Anping [1 ]
Yang, Haijun [1 ]
Li, Jian [1 ]
Wu, Shouxin [2 ]
Zhao, Jiangman [2 ]
Meng, Peng [2 ]
Zhou, Fuyou [1 ]
机构
[1] Henan Univ Sci & Technol, Dept Radiat Oncol, Anyang Canc Hosp, Affiliated Hosp 4, Anyang 455000, Peoples R China
[2] Biotecan Pharmaceut Co Ltd, Shanghai Zhangjiang Inst Med Innovat, Shanghai 201204, Peoples R China
来源
TRANSLATIONAL ONCOLOGY | 2021年 / 14卷 / 06期
基金
中国国家自然科学基金;
关键词
Esophageal squamous cell carcinoma; Early recurrence; Esophagectomy; Minimum p-value; Post-relapse treatment; PROGRESSION-FREE SURVIVAL; CANCER; THERAPY; DEATH;
D O I
10.1016/j.tranon.2021.101066
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Early recurrence after surgery could affect cancerous patients? prognosis, but the definition of early recurrence and its risk factors for esophageal squamous cell carcinoma (ESCC) patients are still unclear. This study analyzed the clinical data of 468 post-surgery recurrent ESCC patients retrospectively. A minimum p -value approach was used to evaluate the optimal cut-off value of recurrence free survival (RFS) to define early recurrence. Risk factors of early recurrence were developed based on a Cox model. The optimal cut-off value of RFS to distinguish early recurrence was 21 months ( p < 0.001). Independent risk factors for early recurrence included tumor locations (HR = 0.562, p < 0.001), pathological T stage (HR = 1.829, p < 0.001), tumor diameter (HR = 1.344, p = 0.039), positive lymph nodes (HR = 1.361, p < 0.001), and total resected lymph nodes (HR = 1.271, p = 044). For the late recurrent patients, there was a much more significant survival advantage for recurrence after concurrent chemoradiotherapy than that after sequential chemoradiotherapy and radiotherapy alone ( p = 0.0066). In conclusion, this study defined 21 months of RFS as early recurrence and also identified its risk factors. Concurrent chemoradiotherapy was suggested as preferred post-relapse treatment for late recurrent ESCC patients.
引用
收藏
页数:8
相关论文
共 26 条
  • [11] Role of Postoperative C-Reactive Protein Levels in Predicting Prognosis After Surgical Treatment of Esophageal Cancer
    Ibuki, Yuta
    Hamai, Yoichi
    Hihara, Jun
    Emi, Manabu
    Taomoto, Junya
    Furukawa, Takaoki
    Yamakita, Ichiko
    Kurokawa, Tomoaki
    Okada, Morihito
    [J]. WORLD JOURNAL OF SURGERY, 2017, 41 (06) : 1558 - 1565
  • [12] Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.21492, 10.3322/caac.20115, 10.3322/caac.20107]
  • [13] Surrogacy of progression-free survival (PFS) for overall survival (OS) in esophageal cancer trials with preoperative therapy: Literature-based meta-analysis
    Kataoka, K.
    Nakamura, K.
    Mizusawa, J.
    Kato, K.
    Eba, J.
    Katayama, H.
    Shibata, T.
    Fukuda, H.
    [J]. EJSO, 2017, 43 (10): : 1956 - 1961
  • [14] Clinical outcomes and prognostic factors of chemoradiotherapy for postoperative lymph node recurrence of esophageal cancer
    Kawamoto, Terufumi
    Nihei, Keiji
    Sasai, Keisuke
    Karasawa, Katsuyuki
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (03) : 259 - 264
  • [15] Predictors of Early Recurrence for Node-Negative T1 to T2b Non-Small Cell Lung Cancer
    Kiankhooy, Armin
    Taylor, Matthew D.
    LaPar, Damien J.
    Isbell, James M.
    Lau, Christine L.
    Kozower, Benjamin D.
    Jones, David R.
    [J]. ANNALS OF THORACIC SURGERY, 2014, 98 (04) : 1175 - 1183
  • [16] Progression-Free Survival and Time to Progression as Real Surrogate End Points for Overall Survival in Advanced Breast Cancer: A Meta-Analysis of 37 Trials
    Li, Ling
    Pan, Zhanyu
    [J]. CLINICAL BREAST CANCER, 2018, 18 (01) : 63 - 70
  • [17] Lin M., 2019, GASTR CANC
  • [18] Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival
    Llovet, Josep M.
    Montal, Robert
    Villanueva, Augusto
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (06) : 1262 - 1277
  • [19] Locoregional Tumor Extension and Preoperative Smoking are Significant Risk Factors for Early Recurrence After Esophagectomy for Cancer
    Mantziari, Styliani
    Allemann, Pierre
    Winiker, Michael
    Demartines, Nicolas
    Schafer, Markus
    [J]. WORLD JOURNAL OF SURGERY, 2018, 42 (07) : 2209 - 2217
  • [20] Sobin L.H., 2009, UICC: TNM classification of malignant tumors, V7th